Rezulin Attorney

By the time the FDA announcement of the Rezulin recall on March 21, 2000 was made, Warner-Lambert had already made $2.1 billion in sales and an estimated two million people had already taken Rezulin. Rezulin had remained on the U.S. market for over three years despite the knowledge and reports of serious adverse effects prior to the diabetes drug's approval. Suspected of causing 391 deaths, including hundreds of liver damage cases, Warner-Lambert has found themselves in the middle of countless Rezulin lawsuits and investigations. The most recent Rezulin case has been decided, awarding $24.9 million in punitive damages to the family of a woman who died after taking Rezulin diabetes drug due to liver damage. Warner-Lambert, Rezulin manufacturer, is planning on appealing the decision. The jury ruled that Warner-Lambert was guilty of negligence in developing and marketing Rezulin.

Rezulin has been described by Public Citizen's Dr. Sidney Wolfe as "one of the most dangerous drugs" while on the market. Consumers readily take prescription drugs administered to them because FDA approval has been made on the drug, but recent studies published on May 1, 2002, in the American Medical Association indicate that one in five new drugs have serious side effects that will go undetected or undisclosed long after the FDA approves them.

In the case of Rezulin, the side effects had already been detected prior to approval, yet the diabetes drug was still able to receive a "fast track" status, putting the dangerous drug on the market in just six months. There has been a rush for new medicines to enter the market that continues to compromise the safety of consumers. The diabetes drug, first removed by the British government back in December of 1997, was not removed in the U.S. because FDA officials claimed they were waiting to be sure two newer diabetes drugs were safer. Wolfe thinks, "It is just another example of how low the standards have gotten at FDA." Click here for a Rezulin Attorney

Rezulin was approved under conditions that many FDA physicians describe as lowered safety standards. During the course Rezulin was on the U.S. market the FDA strengthened the Rezulin labeling four times due to the continuation of liver failure deaths and injuries Rezulin was associated to, the first one occurring in November of 1997 until the Rezulin recall in 2000. Prosecutors that were assigned to the office of the U.S. attorney questioned FDA officials in July 2000. They explored the Warner-Lambert's conduct, as well as the FDA's conduct.

Rezulin Attorneys created this site to educate consumers of the dangerous and deadly Rezulin side effects that have resulted from negligence. Rezulin attorneys are available for anyone wishing to obtain more information regarding the Rezulin recall, or who wish to receive a free consultation for the Rezulin side effects that you have, or still are, experiencing. Contact a Rezulin Attorney to learn if you are entitled to a large compensation for the damages and suffering that have resulted from taking Rezulin.

top